Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP3 | P42574 | 1/20 | 0.80 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.80 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.80 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.80 |
| ▸ | ANO1 | Q5XXA6 | 14/20 | 0.70 |
| ▸ | MEN1 | O00255 | 4/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.60 |
| ▸ | LMNA | P02545 | 1/20 | 0.60 |
| ▸ | HPGD | P15428 | 1/20 | 0.60 |
| ▸ | GFER | P55789 | 1/20 | 0.60 |
| ▸ | NPC1 | O15118 | 2/20 | 0.59 |
| ▸ | RAB9A | P51151 | 2/20 | 0.59 |
| ▸ | ANO2 | Q9NQ90 | 1/20 | 0.59 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4114544 | 0.92 | CASP3 (0.85) | CASP3SENP8SENP7SENP6ANO1 | |
| SCHEMBL3628774 | 0.91 | CASP3 (0.83) | CASP3SENP8SENP7SENP6ANO1 | |
| SCHEMBL4124608 | 0.90 | CASP3 (0.72) | CASP3SENP8SENP7SENP6ANO1 | |
| SCHEMBL13926174 | 0.90 | ANO1 (0.72) | CASP3SENP8SENP7SENP6ANO1 | |
| SCHEMBL4129079 | 0.89 | CASP3 (0.80) | CASP3SENP8SENP7SENP6ANO1 | |
| SCHEMBL3628387 | 0.89 | CASP3 (1.00) | CASP3SENP8SENP7SENP6ANO1 | |
| SCHEMBL15233170 | 0.88 | CASP3 (0.71) | CASP3SENP8SENP7SENP6ANO1 | |
| SCHEMBL12414185 | 0.87 | CASP3 (0.71) | CASP3SENP8SENP7SENP6ANO1 | |
| SCHEMBL12271278 | 0.87 | ANO1 (0.80) | ANO1MEN1KMT2ARAB9AANO2 | |
| SCHEMBL3631055 | 0.87 | CASP3 (0.64) | CASP3SENP8SENP7SENP6ANO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8263641-B2 | Compounds that modulate intracellular calcium | CALCIMEDICA, INC. (US) | 2012-09-11 | — | — | US | claimed |
| US-20090137659-A1 | COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM | CALCIMEDICA, INC. (US) | 2009-05-28 | — | — | US | claimed |
| US-9234165-B2 | Low-VOC cleaning substrates and compositions consisting of a solvent mixture | THE CLOROX COMPANY (US) | 2016-01-12 | — | — | US | disclosed |
| US-9006165-B2 | Low-VOC cleaning substrates and compositions comprising a cationic biocide and glycol ether solvent | THE CLOROX COMPANY (US) | 2015-04-14 | — | — | US | disclosed |
| US-20150079140-A1 | LOW-VOC CLEANING SUBSTRATES AND COMPOSITIONS | THE CLOROX COMPANY (US) | 2015-03-19 | — | — | US | disclosed |
| US-20140150193-A1 | LOW-VOC CLEANING SUBSTRATES AND COMPOSITIONS | THE CLOROX COMPANY (US) | 2014-06-05 | — | — | US | disclosed |
| US-8524765-B2 | Compounds that modulate intracellular calcium | CALCIMEDICA, INC. (US) | 2013-09-03 | — | — | US | disclosed |
| US-8524765-B2 | Compounds that modulate intracellular calcium | CALCIMEDICA, INC. (US) | 2013-09-03 | — | — | US | disclosed |
| US-20120289587-A1 | COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM | CALCIMEDICA, INC. (US) | 2012-11-15 | — | — | US | disclosed |
| US-20120289587-A1 | COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM | CALCIMEDICA, INC. (US) | 2012-11-15 | — | — | US | disclosed |
| US-8263641-B2 | Compounds that modulate intracellular calcium | CALCIMEDICA, INC. (US) | 2012-09-11 | — | — | US | disclosed |
| US-20090246240-A1 | DRY BACTERICIDAL NONWOVEN WIPE | TWIN BROOK CAPITAL PARTNERS, LLC | 2009-10-01 | — | — | US | disclosed |
| US-20090137659-A1 | COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM | CALCIMEDICA, INC. (US) | 2009-05-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120289587-A1 | COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM | ORAI1, SARAF, RYR2 | CASP3 2232/4885SENP8 3756/4885SENP7 3940/4885 |
| US-20150079140-A1 | LOW-VOC CLEANING SUBSTRATES AND COMPOSITIONS | VCL, SMURF1, SMURF2 | CASP3 2191/4885SENP8 1393/4885SENP7 431/4885 |
| US-20090137659-A1 | COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM | ORAI1, SARAF, RYR2 | CASP3 2232/4885SENP8 3756/4885SENP7 3940/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.